Athenais Boucly

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Is reduced right ventricular power after sotatercept beneficial?

Is reduced right ventricular power after sotatercept beneficial?

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: June 13, 2026

European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension.

European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: June 01, 2026

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Journal: Science translational medicine

Published: May 20, 2026

Does the method matter? Direct fick vs thermodilution in the haemodynamic assessment of pulmonary hypertension.

Does the method matter? Direct fick vs thermodilution in the haemodynamic assessment of pulmonary hypertension.

Journal: ESC heart failure

Published: March 27, 2026

ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly.

ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly.

Journal: ERJ open research

Published: March 26, 2026

Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients.

Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 21, 2026

Efficacy and safety of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension associated with sickle cell disease.

Efficacy and safety of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension associated with sickle cell disease.

Journal: Respiratory medicine and research

Published: January 18, 2026

Diagnostic and management dilemmas in pulmonary hypertension.

Diagnostic and management dilemmas in pulmonary hypertension.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: January 11, 2026

Impact of Pulmonary Arterial Hypertension Therapies on Gas Exchange in Portopulmonary Hypertension.

Impact of Pulmonary Arterial Hypertension Therapies on Gas Exchange in Portopulmonary Hypertension.

Journal: Chest

Published: October 27, 2025

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

Journal: The European respiratory journal

Published: October 17, 2025

Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.

Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.

Journal: Cardiovascular research

Published: October 13, 2025

Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.

Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.

Journal: American journal of respiratory and critical care medicine

Published: September 12, 2025

Showing 1-12 of 111

Last Updated: 09/26/2026